Member Info for Baffyman

Or reply to a text that has RNS as the title. lol

Chartmy, great rallying call

Smart presentation, beyond my knowledge, BUT
it looks as though Affycell could be massive in it's own right.
Hope they push it as fast as is reasonably possible.
Have a very good feeling this is the week, like most do on here.

Alex, they cant even spell affimer correctly, so is the rest of report accurate?

Can't understand my people are so paranoid about the exa t date of the news.
Surely it's the content that is the important driver for this share.
I know it's frustrating having to wait, but they will publish the rns when they are ready.
Then it's zoom time, i hope, as I'm all in now.

What's the point of these posts?
Is it a long winded way of advertising a book?
No link to AVCT

Well said Bein, the man/woman is a sewer rat imo.
FILTER and don't engage.

Theres a lot of doubt on RedX board:
"The report says the unnamed drug is given by infusion whereas my understanding is that RXC004 is given orally."
So it's not nailed on it's them.

Just shows in the present climate, how hard it is to raise cash.
Avacta deal was exceptional.
Poor old Yourgene today started off at 1.85p and have raised at .3p (80% reduction)
https://www.lse.co.uk/rns/YGEN/proposed-capital-raising-z5ik04b7knkwu6w.html

RMFatGB, Very good find.
This shows that the trials are large and complicated for the drugs on this platform.
Hence my theory is still that the PLATFORM will be sold off, retaining affimers and diagnostics within the company.
This scenario is based on successful news in early Jan of course.
I've chucked in the kitchen sink as I'm that convinced on the tech, but plse dyor.
Merry Xmas to you all.
(Precision is big but affimers are bigger)

From RNS, Therapeutics:
" There are five programmes in the pipeline as well as several global research collaborations and licensing partnerships."
6000, 3996 and 3 others,
This is GREAT NEWS
(others are AVA028, AVA021 & TMAC) with affimers making an appearance

EGTP - Money is on Monday ,
don't let me down AS.
Then whoosh.
Over and out til after Xmas.

I hope Trinity don't get paid for putting out so much shiite on values.
Yesterday there was an offer on phase1/2 drug by novartis which valued it at over $500m in total, YET
our precision platform is valued at $325m in TOTAL which could include up to 14 candidates.
This is pathetic

My opinion for what it's worth, is that Avacta seems to have slit the company into 3 categories.
These are precision, affimers and diagnostics.
I think they will sell precision and keep the other 2.
I know there is an overlap with precision and affimers but I think that Avacta will keep ALL affimer rights as it's a very large untapped market for lots of uses of affimers.
My take is £10bn for precision after proof of concept plus a royalty on profits.
I can but dream, but this is realistic in my view.
gla

Alan??

Great find. If you tab down this also involves both Christie & Sheffield and so far 33% of those applying have met the criteria.
Interesting

People sit here in their ivory towers throwing around disparaging remarks like poor management.
Scenario: Suppose the last candidate had to drop out of the trial at a late stage, so has to be replaced. This can throw the schedule back by weeks/months.
Is it foreseen? No
Can it be planned for? v hard when you don't know it will happen.
Give them a break, THEY are the experts NOT the general public on a keyboard.
Patience is required, know it's hard when we're so close, but throwing out negative comments does not help anyone.
There is another option: If you think so badly of the company or don't believe in it's running you could just sell up and move on.
gla who are invested and hope this month or next year is the one.

I also tried IG with no luck.

Again hiding a lot of buys, they upped the ask from 112 to 115 at 9, so all trades after this look like sells (my buy at 0924hrs proves this).
Got to start going up soon, looking forward to Thurs as it MAY be the day, if not then soon. gla

Think about it this way:
Big sell, then fundraise at a lower sp.
II's sell shares they don't own on a T+10 basis (at 3p).
They accumulate fundraise shares at 2p and hand them over. Quick profit.
Who says AIM is not dodgy, seen this many times before on fundraises.
All imo of course, but there is a pattern.